KIR2DL1 and COVID-19: Regarding KIR gene polymorphisms, the combination of the activating receptor KIR2DS2 with the HLA-C1 allele has been associated with reduced mortality in COVID-19 patients, whereas increased expression of the inhibitory receptor KIR2DL1 has been observed in individuals with severe disease [24,25].